{"schema_version":"secwatch.filing_event.v1","accession":"0001376474-25-000100","form_type":"8-K","ticker":"NVEC","cik":"0000724910","company_name":"NVE CORP /NEW/","filed_at":"2025-01-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.202606+00:00","generated_at":"2026-05-27T21:27:45.358097+00:00","sec_items":["2.02","8.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"NVE Q3 revenue down 25% to $5.06M, net income falls 27% to $0.63 EPS; $1.00 dividend declared","bullets":["Q3 total revenue $5.06M, down 25% YoY; product sales fell 22% and contract R&D revenue dropped 74%.","Q3 net income $3.05M ($0.63 diluted EPS), vs $4.18M ($0.87 EPS) a year ago.","First nine months revenue $18.6M (-18% YoY); net income $11.2M ($2.31 EPS), down 16%.","Board approved $1.00 per share quarterly dividend, payable Feb 28, 2025 to holders of record Feb 3, 2025.","CEO Dan Baker cited challenging industry conditions for the sales decline."],"urls":{"canonical":"https://secwatch.observer/filing/0001376474-25-000100","json":"https://secwatch.observer/filing/0001376474-25-000100.json","markdown":"https://secwatch.observer/filing/0001376474-25-000100.md","text":"https://secwatch.observer/filing/0001376474-25-000100.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/724910/000137647425000100/0001376474-25-000100-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/724910/000137647425000100/nvec-20250122.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T21:27:45.358097+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}